During the past few decades, dietary management and medication for blood glucose and lipid reduction have been the main therapies for T2DM, including biguanides, sulfonylureas, thiazolidinediones, insulin, statins, and others. The gene discussed is INS; the disease is type 2 diabetes mellitus.